Skip to main content

Frontiers Clinical and Translational Research Pilot Study

The Dr. Lauren Aaronson Frontiers Clinical and Translational Research Pilot Study provides awards to support the growth of interdisciplinary, investigator-initiated clinical and translational research across a broad range of scientific disciplines. It is expected that all research supported by Frontiers pilot project awards will result in one or more publications in a peer-reviewed journal and will provide critical preliminary data to support extramural applications.

Applications are now being accepted for the 2020-2021 Dr. Lauren S. Aaronson Frontiers Clinical and Translational Research Pilot Study program.

View the full Request for Proposals Application Phase 1: Letter of Intent [PDF]

Frontiers will select up to six principal investigators to submit full applications following review of an initial Letter of Intent. A maximum of $50,000 each is available for up to three qualified applicants.

  • All LOIs must be submitted online via REDCap
  • A PDF preview of all required information is available here

To accomplish the NCATS goal "to get more treatments to more patients more quickly", the Frontiers Clinical and Translational Pilot Study Program promotes research that will compete successfully for extramural funding, with special emphasis on research targeting the special needs of vulnerable, rural, rare and marginalized groups who historically have not been involved in clinical and translational research.

Key Dates:

  • Posted Date: September 16, 2019
  • Letter of Intent Due: November 1, 2019
  • Notification to LOI Applicants: December 1, 2019
  • Full Proposals Due: March 1, 2020
  • Notification of Award: April 1, 2020
  • Project Start Date (pending NCATS approval): July 1, 2020

Eligibility

Applicants must have a faculty appointment at a Frontiers institution and be eligible to independently submit extramural research grant applications. Only one proposal will be accepted per applicant. An applicant may be a collaborator on other proposals.

All questions regarding the Dr. Lauren Aaronson Frontiers Clinical and Translational Research Pilot Study should be directed to Frontiers Administrative Director Jen Baker at jbaker16@kumc.eduor 913-588-6290.

Last modified: Sep 17, 2019
ID=x31852